Insiders · Profile

Nuechterlein Carole

Director at Aligos Therapeutics. Filing since 25 Oct 2023. CIK 0001665133

Company

Date

Role

Action

Shares

Amount

Of holding

ALGS Aligos Therapeutics, Inc.

25 Oct 2023

Director

Bought

7,933,601

$6.00M

257%

1 decision on file.